JP2007516232A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516232A5 JP2007516232A5 JP2006533319A JP2006533319A JP2007516232A5 JP 2007516232 A5 JP2007516232 A5 JP 2007516232A5 JP 2006533319 A JP2006533319 A JP 2006533319A JP 2006533319 A JP2006533319 A JP 2006533319A JP 2007516232 A5 JP2007516232 A5 JP 2007516232A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- glial
- type
- tumor antigen
- medicament according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47323803P | 2003-05-23 | 2003-05-23 | |
| US60/473,238 | 2003-05-23 | ||
| US54829904P | 2004-02-27 | 2004-02-27 | |
| US60/548,299 | 2004-02-27 | ||
| PCT/US2004/016121 WO2004112829A2 (en) | 2003-05-23 | 2004-05-21 | Compositions and methods for the diagnosis and treatment of tumors of glial origin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007516232A JP2007516232A (ja) | 2007-06-21 |
| JP2007516232A5 true JP2007516232A5 (https=) | 2007-08-02 |
| JP4703567B2 JP4703567B2 (ja) | 2011-06-15 |
Family
ID=33544287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533319A Expired - Fee Related JP4703567B2 (ja) | 2003-05-23 | 2004-05-21 | 膠細胞起源の腫瘍の診断と治療のための組成物と方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20050112129A1 (https=) |
| EP (1) | EP1628679A2 (https=) |
| JP (1) | JP4703567B2 (https=) |
| KR (1) | KR20060015296A (https=) |
| AU (1) | AU2004249125A1 (https=) |
| CA (1) | CA2524567A1 (https=) |
| MX (1) | MXPA05012613A (https=) |
| NZ (1) | NZ543751A (https=) |
| WO (1) | WO2004112829A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| AU2002367318B2 (en) * | 2002-01-02 | 2007-07-12 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| WO2004106495A2 (en) | 2003-05-29 | 2004-12-09 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| US7473531B1 (en) * | 2003-08-08 | 2009-01-06 | Colora Corporation | Pancreatic cancer targets and uses thereof |
| US7824685B2 (en) * | 2004-01-26 | 2010-11-02 | Baylor College Of Medicine | RTVP based compositions and methods for the treatment of prostate cancer |
| JP4840866B2 (ja) * | 2005-01-19 | 2011-12-21 | 学校法人慶應義塾 | 癌ワクチン |
| ATE501276T1 (de) * | 2005-07-26 | 2011-03-15 | Council Scient Ind Res | Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen |
| ES2330904B1 (es) * | 2005-09-21 | 2010-09-23 | Fundacio Centre De Recerca En Sanitat Animal | Polinucleotidos de haemophilus parasuis y su uso. |
| WO2007059170A2 (en) * | 2005-11-15 | 2007-05-24 | University Of South Florida | Detection of pkc-iota as a biomarker for brain tumorigenesis |
| CA2643737C (en) | 2006-03-13 | 2020-05-05 | Mubio Products Bv | Cancer vaccine |
| EP2091565A2 (en) * | 2006-11-29 | 2009-08-26 | Genentech, Inc. | Method of diagnosing and treating glioma |
| US20090011060A1 (en) * | 2007-07-06 | 2009-01-08 | Peter Koepke | Campsiandra angustifolia extract and methods of extracting and using such extract |
| ES2700141T3 (es) | 2007-08-02 | 2019-02-14 | Gilead Biologics Inc | Anticuerpos inhibidores LOXL2 y usos de los mismos |
| EP2545938A1 (en) | 2007-08-03 | 2013-01-16 | Abbott Biotherapeutics Corp. | Therapeutic use of anti-tweak receptor antibodies |
| US7879369B2 (en) | 2007-09-18 | 2011-02-01 | Selvamedica, Llc | Combretum laurifolium Mart. extract and methods of extracting and using such extract |
| BRPI0906261A2 (pt) * | 2008-03-31 | 2015-07-07 | Genentech Inc | "métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente" |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| EP2216399A1 (en) * | 2009-01-30 | 2010-08-11 | Université de la Méditerranée | Human soluble CD146, preparation and uses thereof |
| SG178845A1 (en) | 2009-08-21 | 2012-04-27 | Gilead Biologics Inc | Catalytic domains from lysyl oxidase and loxl2 |
| WO2011022709A1 (en) * | 2009-08-21 | 2011-02-24 | Arresto Biosciences, Inc | In vitro screening assays |
| BR112012019693A2 (pt) | 2010-02-04 | 2017-06-20 | Gilead Biologics Inc | anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles. |
| SG185027A1 (en) * | 2010-05-03 | 2012-11-29 | Genentech Inc | Compositions and methods for the diagnosis and treatment of tumor |
| CN103491978A (zh) * | 2010-10-25 | 2014-01-01 | 明尼苏达大学评议会 | 用于治疗成胶质细胞瘤的治疗组合物 |
| RU2578468C2 (ru) | 2010-12-16 | 2016-03-27 | Дженентек, Инк. | Способы диагностики и лечения, связанные с ингибированием th2 |
| US10260089B2 (en) | 2012-10-29 | 2019-04-16 | The Research Foundation Of The State University Of New York | Compositions and methods for recognition of RNA using triple helical peptide nucleic acids |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CA3012006A1 (en) * | 2017-07-31 | 2019-01-31 | Modern Meadow, Inc. | Yeast strains and methods for controlling hydroxylation of recombinant collagen |
| WO2024107709A2 (en) * | 2022-11-14 | 2024-05-23 | Board Of Regents, The University Of Texas System | Compositions and methods of using nitration resistant ccl2 chemokines |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614191A (en) * | 1995-03-15 | 1997-03-25 | The United States Of America As Represented By The Department Of Health And Human Services | IL-13 receptor specific chimeric proteins and uses thereof |
| US6518061B1 (en) * | 1995-03-15 | 2003-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | IL-13 receptor specific chimeric proteins and uses thereof |
| US6428788B1 (en) * | 1995-03-15 | 2002-08-06 | Penn State University | Compositions and methods for specifically targeting tumors |
| US6150162A (en) | 1998-12-17 | 2000-11-21 | Isis Pharmaceuticals Inc. | Antisense modulation of CD44 expression |
| US6342219B1 (en) * | 1999-04-28 | 2002-01-29 | Board Of Regents, The University Of Texas System | Antibody compositions for selectively inhibiting VEGF |
| US6960651B2 (en) * | 1999-06-29 | 2005-11-01 | Millennium Pharmaceuticals, Inc. | TANGO 332 polypeptides |
| WO2001036685A2 (en) | 1999-11-17 | 2001-05-25 | Nyxis Neurotherapies, Inc. | Differential gene expression in cancer |
| DE60238143D1 (de) * | 2001-09-18 | 2010-12-09 | Genentech Inc | Zusammensetzungen und verfahren für die diagnose von tumoren |
-
2004
- 2004-05-21 EP EP04753019A patent/EP1628679A2/en not_active Withdrawn
- 2004-05-21 JP JP2006533319A patent/JP4703567B2/ja not_active Expired - Fee Related
- 2004-05-21 CA CA002524567A patent/CA2524567A1/en not_active Abandoned
- 2004-05-21 KR KR1020057022428A patent/KR20060015296A/ko not_active Withdrawn
- 2004-05-21 AU AU2004249125A patent/AU2004249125A1/en not_active Abandoned
- 2004-05-21 MX MXPA05012613A patent/MXPA05012613A/es not_active Application Discontinuation
- 2004-05-21 NZ NZ543751A patent/NZ543751A/en unknown
- 2004-05-21 WO PCT/US2004/016121 patent/WO2004112829A2/en not_active Ceased
- 2004-05-24 US US10/852,335 patent/US20050112129A1/en not_active Abandoned
-
2007
- 2007-01-19 US US11/625,272 patent/US8008004B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007516232A5 (https=) | ||
| Kim et al. | First-in-human phase I study of aprutumab ixadotin, a fibroblast growth factor receptor 2 antibody–drug conjugate (BAY 1187982) in patients with advanced cancer | |
| US20110020221A1 (en) | Cancer stem cell expression patterns and compounds to target cancer stem cells | |
| Tolcher et al. | Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer | |
| JP2008546780A5 (https=) | ||
| JP2010537671A5 (https=) | ||
| JP2010510809A5 (https=) | ||
| WO2015066279A2 (en) | Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof | |
| JP2007504280A5 (https=) | ||
| CA2633171A1 (en) | Antibodies against tumor-associated antigenic target (tat) polypeptides | |
| Hicks et al. | The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models | |
| SG170728A1 (en) | Anti-tumor cell antigen antibody therapeutics | |
| JP2009536834A5 (https=) | ||
| JP2011502517A5 (https=) | ||
| AR050642A1 (es) | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/ calicheamicina | |
| JP2010518847A5 (https=) | ||
| Li et al. | Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer | |
| JP2015533788A5 (https=) | ||
| JP2015523852A5 (https=) | ||
| Shao et al. | Ganglioside GD2: a novel therapeutic target in triple‐negative breast cancer | |
| RU2012127351A (ru) | Композиции и способы для диагностики и лечения опухоли | |
| RU2012140451A (ru) | Композиции и способы для диагностики и лечения опухолей | |
| JP2014515600A5 (https=) | ||
| Tsumura et al. | Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool | |
| WO2007127476A3 (en) | Monoclonal antibodies specific for pancreatic endocrine, exocrine or ductal cell |